Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies

被引：26

作者：

Khamashta, MA ^{[1
]}

机构：

[1] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England

来源：

JOURNAL OF AUTOIMMUNITY | 2000年 / 15卷 / 02期

关键词：

lupus; anticardiolipin; lupus anticoagulant;

D O I：

10.1006/jaut.2000.0421

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A major cause of stroke, as well as other arterial and venous thromboembolic disease has been identified-the presence of antiphospholipid antibodies (aPL). Now it is possible to identify individuals positive for aPL and still free of thrombosis. The tests to measure aPL have been standardized (aCL by ELISA and LA by coagulometric assays) and they are routinely performed in patients with SLE and other connective tissue diseases and women with recurrent pregnancy loss. However, very little is known about the risk of thrombosis in individuals positive for aPL but still free of thrombosis. Should these individuals receive any treatment? If so, which one? (C) 2000 Academic Press.

引用

页码：249 / 253

页数：5

共 22 条

[1] PRELIMINARY CLASSIFICATION CRITERIA FOR THE ANTIPHOSPHOLIPID SYNDROME WITHIN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].

ALARCONSEGOVIA, D ;

PEREZVAZQUEZ, ME ;

VILLA, AR ;

DRENKARD, C ;

CABIEDES, J .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) :275-286

[2]

[Anonymous], 1994, BMJ

[3] VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].

BERN, MM ;

LOKICH, JJ ;

WALLACH, SR ;

BOTHE, A ;

BENOTTI, PN ;

ARKIN, CF ;

GRECO, FA ;

HUBERMAN, M ;

MOORE, C .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428

[4] The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects [J].

Cuadrado, MJ ;

Khamashta, MA .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2000, 14 (01) :151-163

[5]

Edwards MH, 1997, CIRCULATION, V96, P4380

[6] Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian Registry [J].

Finazzi, G ;

Brancaccio, V ;

Moia, M ;

Ciavarella, N ;

Mazzucconi, MG ;

Schinco, P ;

Ruggeri, M ;

Pogliani, EM ;

Gamba, G ;

Rossi, E ;

Baudo, F ;

Manotti, C ;

DAngelo, A ;

Palareti, G ;

DeStefano, V ;

Berrettini, M ;

Barbui, T .

AMERICAN JOURNAL OF MEDICINE, 1996, 100 (05) :530-536

[7] ANTICARDIOLIPIN ANTIBODIES AND THE RISK FOR ISCHEMIC STROKE AND VENOUS THROMBOSIS [J].

GINSBURG, KS ;

LIANG, MH ;

NEWCOMER, L ;

GOLDHABER, SZ ;

SCHUR, PH ;

HENNEKENS, CH ;

STAMPFER, MJ .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :997-1002

[8] Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness [J].

Kalra, L ;

Yu, G ;

Perez, I ;

Lakhani, A ;

Donaldson, N .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1236-1239

[9]

Khamashta MA, 2000, HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, P391

[10]

KITTNER SJ, 1992, STROKE S1, V23, P19

← 1 2 3 →